Characterization of oxaliplatin-induced chronic painful peripheral neuropathy in the rat and comparison with the neuropathy induced by paclitaxel

@article{Xiao2012CharacterizationOO,
  title={Characterization of oxaliplatin-induced chronic painful peripheral neuropathy in the rat and comparison with the neuropathy induced by paclitaxel},
  author={Wen Hua Xiao and H. Zheng and Gary J. Bennett},
  journal={Neuroscience},
  year={2012},
  volume={203},
  pages={194-206}
}

Figures and Tables from this paper

Neurochemical characterization of primary sensory neurons in a rat model of bortezomic-induced peripheral neuropathy

The characterization of this animal model of chemotherapy-induced peripheral neuropathy suggests that the neurochemical changes occurring in populations of DRG neurons that are likely involved in pain transmission appear to be an important component of the sensory neuropathy induced by the bortezomib-treatment and may represent the outcome of the molecular machine activated by the drug during the onset and persistence of bortzomib -induced neuropathic pain.

Pharmacological comparison of a nonhuman primate and a rat model of oxaliplatin‐induced neuropathic cold hypersensitivity

The current results indicate that the NHP could serve as a bridge species to improve translatability of preclinical findings into clinically useful treatments for oxaliplatin‐induced peripheral neuropathy.

Characterization of Acute and Chronic Neuropathies Induced by Oxaliplatin in Mice and Differential Effects of a Novel Mitochondria-targeted Antioxidant on the Neuropathies

This model of oxaliplatin-induced neuropathy mimicked patients’ conditions and has potentials to prevent both acute and chronic neuropathies but is only helpful in treatment of acute neuropathy.

Chemotherapy-induced neuropathy: A comprehensive survey.

Chemotherapy-induced peripheral neuropathy.

  • J. Fehrenbacher
  • Biology, Psychology
    Progress in molecular biology and translational science
  • 2015

Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN)

The pathobiology of CIPN is complex as cancer chemotherapy treatment regimens frequently involve drug combinations and there are also subtle differences in the pathobiological consequences of commonly used cancer chemotherapy drugs on peripheral nerves.

Probing the peripheral immune response in mouse models of oxaliplatin-induced peripheral neuropathy highlights their limited translatability.

Though repeated oxaliplatin administration had a systemic effect, it was unable to detect a pain-like behavioural phenotype in response to either cold or mechanical stimuli, so it cannot be commented on whether the observed myeloid changes are associated with OIPN.

Probing the peripheral immune response in mouse models of oxaliplatin-induced peripheral neuropathy highlights their limited translatability

Though repeated oxaliplatin administration had a systemic effect, it was unable to detect a pain-like behavioural phenotype in response to either cold or mechanical stimuli, so it cannot be commented on whether the observed myeloid changes are associated with OIPN.
...

References

SHOWING 1-10 OF 81 REFERENCES

Comparison of oxaliplatin- and cisplatin-induced painful peripheral neuropathy in the rat.

  • E. JosephJ. Levine
  • Biology
    The journal of pain : official journal of the American Pain Society
  • 2009

Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice

It is demonstrated that chronic treatment with oxaliplatin produces neurotoxic changes in BALB/c mice, confirming that this model is a suitable tool to conduct further mechanistic studies of oxali platin-related antineoplastic activity, peripheral neurotoxicity and pain.

A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel

Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy.

Paclitaxel- and vincristine-evoked painful peripheral neuropathies: Loss of epidermal innervation and activation of Langerhans cells

Mice with cisplatin and oxaliplatin-induced painful neuropathy develop distinct early responses to thermal stimuli

This model of platinum drug-induced painful peripheral neuropathy that reflects the differences in early thermal pain responses that are observed in patients treated with either cisplatin or oxaliplatin should be useful in studying the molecular basis for these different pain responses and in designing protective therapeutic strategies.
...